Documentation Independent Pharmacies Patient Care 
Drug Topics
JUNE 11, 2025
POETYK PsA-1 is a randomized, double-blind, placebo-controlled phase 3 trial evaluating the efficacy and safety of deucravacitinib compared to placebo in adult patients with PsA who are naïve to biologic disease-modifying anti-rheumatic medications. of patients who received placebo. References 1.
Drug Topics
JULY 1, 2025
Rite Aid, which was once the third largest pharmacy chain in the United States, announced in May that it filed its second chapter 11 bankruptcy in under 2 years. Although CVS and other chains have purchased patient files from some Rite Aid stores, many patients have been left scrambling for somewhere to get their prescriptions filled.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 7, 2025
KONFIDENT was a randomized, double-blind, placebo-controlled, 3-way crossover phase 3 clinical trial that evaluated the efficacy and safety of sebetralstat for the treatment of hereditary angioedema attacks in adolescent and adult patients. Patients received either 300 mg or 600 mg sebetralstat or placebo. hours for 300 mg and 1.79
Drug Topics
JULY 8, 2025
TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” However, regarding the strength, quantity, and duration of use recommended for these drugs, opinions vary among HCPs and patients. READ MORE: Dermatology Resource Center Pharmacy practice is always changing.
Drug Topics
JUNE 25, 2025
The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines. 7 READ MORE: Immunizations Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patient care tips?
Drug Topics
JUNE 25, 2025
image credit: syahrir / stock.adobe.com While data shows that obesity has been on the rise among children in recent history, the overall complications spurred on by childhood obesity have been well documented. Pharmacy practice is always changing. 1 “Guidelines recommend treating obesity with medications and lifestyle changes.”
Drug Topics
JUNE 11, 2025
5 Despite these advancements in treatment options, the management of PsD remains a challenge for providers looking to improve their patients’ QOL. This led researchers to explore a specific region of the world in order to better document patients’ understanding of the disease. References 1.
Expert insights. Personalized for you.
315 
Let's personalize your content